YURTAYDIN, S. C. Et Al. 2016. Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study. AASLD 2016 .

YURTAYDIN, S. C., İDİLMAN, R., KALKAN, Ç., KARAKAYA, M. F., ÇALIŞKAN KARTAL, A., KESKİN, O., ... KARATAYLI, E.(2016). Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study . AASLD 2016

YURTAYDIN, SÜLEYMAN Et Al. "Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study," AASLD 2016, 2016

YURTAYDIN, SÜLEYMAN C. Et Al. "Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study." AASLD 2016 , 2016

YURTAYDIN, S. C. Et Al. (2016) . "Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study." AASLD 2016 .

@conferencepaper{conferencepaper, author={SÜLEYMAN CİHAN YURTAYDIN Et Al. }, title={Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study}, congress name={AASLD 2016}, city={}, country={}, year={2016}}